Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD

Kangzhe Xie^{1

2}, Tamara Ortiz Cerda^{1

2

3}, Angie Schroder^{1

2}, Nicolette Shiung^{1

2}, Bruno Lemos Wimmer^{1

2

4}, Belal Chami^{1

2}, Paul K Witting^{1

2}

Affiliations

¹ Redox Biology Group, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia.
² Charles Perkins Centre, The University of Sydney, NSW, 2006Australia.
³ Department of Normal and Pathological Cytology and Histology, Faculty of Medicine, University of Seville, Spain. Avda. Sánchez-Pizjuán s/n 41009 Sevilla, Spain.
⁴ International internship, Department of Life Sciences, Faculty of Chemistry, The University of Konstanz, BW, 78464 Konstanz, Germany.

PMID: 37527412
PMCID: PMC10393069
DOI: 10.1093/ibd/izad133

Comment

Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD

Kangzhe Xie et al. Inflamm Bowel Dis. 2023.

. 2023 Aug 1;29(8):e32.

doi: 10.1093/ibd/izad133.

Authors

Kangzhe Xie^{1

2}, Tamara Ortiz Cerda^{1

2

3}, Angie Schroder^{1

2}, Nicolette Shiung^{1

2}, Bruno Lemos Wimmer^{1

2

4}, Belal Chami^{1

2}, Paul K Witting^{1

2}

Affiliations

¹ Redox Biology Group, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia.
² Charles Perkins Centre, The University of Sydney, NSW, 2006Australia.
³ Department of Normal and Pathological Cytology and Histology, Faculty of Medicine, University of Seville, Spain. Avda. Sánchez-Pizjuán s/n 41009 Sevilla, Spain.
⁴ International internship, Department of Life Sciences, Faculty of Chemistry, The University of Konstanz, BW, 78464 Konstanz, Germany.

PMID: 37527412
PMCID: PMC10393069
DOI: 10.1093/ibd/izad133

No abstract available

PubMed Disclaimer

Conflict of interest statement

None of the authors named here have any conflict to declare.

Comment on

Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn's Disease.
Schroder AL, Chami B, Liu Y, Doyle CM, El Kazzi M, Ahlenstiel G, Ahmad G, Pathma-Nathan N, Collins G, Toh J, Harman A, Byrne S, Ctercteko G, Witting PK. Schroder AL, et al. Inflamm Bowel Dis. 2022 Mar 30;28(4):586-598. doi: 10.1093/ibd/izab239. Inflamm Bowel Dis. 2022. PMID: 34724042 Free PMC article.
Low-density Granulocytes as a Novel Biomarkers of Disease Activity in IBD.
Zhu N, Zhu J, Mei Q. Zhu N, et al. Inflamm Bowel Dis. 2023 Aug 1;29(8):e31. doi: 10.1093/ibd/izad136. Inflamm Bowel Dis. 2023. PMID: 37527413 No abstract available.

References

1. Mihaila AC, Ciortan L, Macarie RD, et al. . Transcriptional profiling and functional analysis of N1/N2 neutrophils reveal an immunomodulatory effect of S100A9-blockade on the pro-inflammatory N1 subpopulation. Front Immunol. 2021;12:708770. eCollection. - PMC - PubMed
1. Saiki T. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J. 1998;45(1):69-73. - PubMed
1. Swaminathan A, Borichevsky GM, Edwards TS, et al. . Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease. J Crohn’s Colitis. 2022;16(12):1862-1873. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD

Affiliations

Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD

Authors

Affiliations

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources